跳至主要内容
临床试验/JPRN-UMIN000044768
JPRN-UMIN000044768已完成未知

A study on the effect of the test food on immunological functions on healthy adults. -A placebo-controlled, randomized, double-blind clinical trial- - A study on the effect of the test food on immunological functions on healthy adults

IMEQRD Co., Ltd.0 个研究点目标入组 80 人开始时间: 2021年11月11日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Those who are currently undergoing treatment for any disease. Also, those who receive medical treatments from medical doctors via drugs or traditional Chinese medicines. 2.Those who receive diet or exercise therapies by doctors. 3.Those who have severe diseases or history of severe diseases. 4.Those who have allergic dermatitis, allergic rhinitis, bronchial asthma, and chronic bronchitis. 5.Those who have currently been taking drugs, quasi-drug products, and foods or supplements which have health claims. However, those who can discontinue taking these materials during the trial period after obtaining informed consent will be allowed to join the trial. 6.Those who have currently been taking yogurts or beverages, which include Lactobacillus and/or Bifidobacterium for being healthy. However, those who can discontinue taking these foods during the trial period after obtaining informed consent will be allowed to join the trial. 7.Those who received the vaccination against SARS-CoV2 after May 2021. Also, those who receive the vaccination during the trial period. 8.Those who have a drug allergy or a food allergy. 9.Those who work on the night shift and the shiftwork. 10.Heavy drinkers who drink over 60 g alcohol/day. 11.Those who have a smoking habit (over 21 cigarettes/day). 12.Those who are planning extremely change their lifestyle (such as diet, sleep, or exercise) during the trial period. 13.Those who are currently pregnant or breastfeeding, or those who are planning to pregnant during the trial period. 14.Those who are planning travels to foreign countries during the trial period. 15.Those who joined other clinical trials from 1 month before obtaining informed consent in this trial, or those who have currently been joined other clinical trials. Also, those who are planning to join other clinical trials. 16.Those who are unsuitable for this trial that judged by the principal investigator.

研究者

发起方
IMEQRD Co., Ltd.

相似试验